GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Pharma Holding Inc (STU:XQJ0) » Definitions » Cyclically Adjusted PS Ratio

China Pharma Holding (STU:XQJ0) Cyclically Adjusted PS Ratio : 0.02 (As of Jun. 07, 2024)


View and export this data going back to 2009. Start your Free Trial

What is China Pharma Holding Cyclically Adjusted PS Ratio?

As of today (2024-06-07), China Pharma Holding's current share price is €2.68. China Pharma Holding's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €113.10. China Pharma Holding's Cyclically Adjusted PS Ratio for today is 0.02.

The historical rank and industry rank for China Pharma Holding's Cyclically Adjusted PS Ratio or its related term are showing as below:

STU:XQJ0' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.02   Med: 0.25   Max: 1.58
Current: 0.02

During the past years, China Pharma Holding's highest Cyclically Adjusted PS Ratio was 1.58. The lowest was 0.02. And the median was 0.25.

STU:XQJ0's Cyclically Adjusted PS Ratio is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.05 vs STU:XQJ0: 0.02

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

China Pharma Holding's adjusted revenue per share data for the three months ended in Mar. 2024 was €0.096. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €113.10 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


China Pharma Holding Cyclically Adjusted PS Ratio Historical Data

The historical data trend for China Pharma Holding's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Pharma Holding Cyclically Adjusted PS Ratio Chart

China Pharma Holding Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.26 0.62 0.92 0.24 0.04

China Pharma Holding Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.10 0.04 0.04 0.02

Competitive Comparison of China Pharma Holding's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, China Pharma Holding's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Pharma Holding's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Pharma Holding's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where China Pharma Holding's Cyclically Adjusted PS Ratio falls into.



China Pharma Holding Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

China Pharma Holding's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=2.68/113.1
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Pharma Holding's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, China Pharma Holding's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.096/115.2271*115.2271
=0.096

Current CPI (Mar. 2024) = 115.2271.

China Pharma Holding Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 5.174 98.200 6.071
201409 4.954 98.900 5.772
201412 3.097 99.000 3.605
201503 6.034 99.900 6.960
201506 5.798 99.500 6.714
201509 4.577 100.500 5.248
201512 4.741 100.600 5.430
201603 3.749 102.200 4.227
201606 3.615 101.400 4.108
201609 3.194 102.400 3.594
201612 5.720 102.600 6.424
201703 3.522 103.200 3.932
201706 2.977 103.100 3.327
201709 3.042 104.100 3.367
201712 3.729 104.500 4.112
201803 3.364 105.300 3.681
201806 3.116 104.900 3.423
201809 2.258 106.600 2.441
201812 3.269 106.500 3.537
201903 2.972 107.700 3.180
201906 2.608 107.700 2.790
201909 2.475 109.800 2.597
201912 3.146 111.200 3.260
202003 1.830 112.300 1.878
202006 3.841 110.400 4.009
202009 2.337 111.700 2.411
202012 2.753 111.500 2.845
202103 2.172 112.662 2.221
202106 2.198 111.769 2.266
202109 1.828 112.215 1.877
202112 2.675 113.108 2.725
202203 1.537 114.335 1.549
202206 1.573 114.558 1.582
202209 1.984 115.339 1.982
202212 2.142 115.116 2.144
202303 0.227 115.116 0.227
202306 0.511 114.558 0.514
202309 0.639 115.339 0.638
202312 0.186 114.781 0.187
202403 0.096 115.227 0.096

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


China Pharma Holding  (STU:XQJ0) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


China Pharma Holding Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of China Pharma Holding's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


China Pharma Holding (STU:XQJ0) Business Description

Traded in Other Exchanges
Address
Second Floor, No. 17, Jinpan Road, Hainan Province, Haikou, CHN, 570216
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

China Pharma Holding (STU:XQJ0) Headlines

No Headlines